Working…
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Response Inhibition Training for Children With Williams Syndrome (WSRIT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02212314
Recruitment Status : Completed
First Posted : August 8, 2014
Last Update Posted : May 31, 2017
Sponsor:
Information provided by (Responsible Party):
Bonita P Klein-Tasman, University of Wisconsin, Milwaukee

Brief Summary:
The investigators will conduct a pilot study investigating the effectiveness of a computerized response inhibition training program at reducing the response inhibition difficulties often seen in children with Williams syndrome ages 10-17. The investigators hypothesize that after completing the training program, children with Williams syndrome will show improvement on computerized measures of response inhibition and on parent measures of impulsivity.

Condition or disease Intervention/treatment Phase
Williams Syndrome Behavioral: Response Inhibition Training Not Applicable

Detailed Description:
Behavioral characteristics of individuals with Williams syndrome include eagerness to approach and interact with others (including strangers), repeated questions especially about upcoming events, and difficulties with attention, impulsivity, and inhibition. There is very little systematic research about the kinds of interventions that are most useful for children with Williams syndrome to support optimal psychosocial functioning, and of the effectiveness of such interventions. We will conduct a pilot study of a potential intervention to address the response inhibition difficulties associated with Williams syndrome. The investigators will examine the utility of an online, web-based computerized cognitive retraining program aimed at addressing impulsivity and inhibition difficulties in 20 children, ages 10-17, with WS. The engaging training program has shown some utility in other populations, including children with tic disorders and trichotillomania. The investigators will examine the acceptability and feasibility of the treatment approach, as well as its impact on performance on experimental measures of impulsivity and on everyday psychosocial functioning as rated by parents; this study will consist of a small-scale pilot Randomized Clinical Trial with wait list. Through this novel work, we hope to develop and tune this approach for optimal outcomes and to demonstrate the promise of this intervention to address common challenges of people with Williams syndrome in the area of inhibition.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 25 participants
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Developing Treatments to Improve Psychosocial Functioning in Children With Williams Syndrome Part 1: Response Inhibition Training for Children With Williams Syndrome
Study Start Date : May 2014
Actual Primary Completion Date : May 2016
Actual Study Completion Date : May 2016


Arm Intervention/treatment
Experimental: Response Inhibition Training
Treatment group will receive immediate treatment after pre-test.
Behavioral: Response Inhibition Training
Computerized response inhibition training will be delivered via the Internet for 10 individual sessions.

No Intervention: Waitlist Crossover
Waitlist group will not receive intervention while treatment group is active, but waitlist group will be offered treatment after post-test is completed.



Primary Outcome Measures :
  1. Cognitive Inhibition Tasks [ Time Frame: 5-7 weeks and 3 months ]
    Three measures of response inhibition that were administered to children at pre-test will be administered after the 5-7-week training and again at a 3-month follow-up. Measures include computer-administered Motor Stroop task, Stop Signal task, and Go/No-Go Task.


Secondary Outcome Measures :
  1. Conners-3 [ Time Frame: 5-7 weeks and 3 months ]
    The Conners-3 will be administered to parents at post-intervention and again at follow-up to assess changes in attention and impulsivity.

  2. Emotion Regulation Checklist [ Time Frame: 5-7 weeks and 3 months ]
    The Emotion Regulation Checklist will be administered to parents at post-intervention and follow-up to assess changes in the child's ability to regulate emotions.

  3. Positive and Negative Affect Scale [ Time Frame: 5-7 weeks and 3 months ]
    The PANAS will be administered to parents at post-intervention and follow-up to assess changes in child positive and negative affect.

  4. Question-Asking Questionnaire [ Time Frame: 5-7 weeks and 3 months ]
    The QAQ will be administered to parents at post-intervention and follow-up to assess changes in amount and frequency of child anticipatory question asking.

  5. Spence Children's Anxiety Scale [ Time Frame: 5-7 weeks, 3 months ]
    The SCAS will be administered to parents at post-intervention and follow-up to assess changes in child anxieties.

  6. MINI Kid 6.0 Parent Version [ Time Frame: 5-7 weeks and 3 months ]
    The MINI Kid 6.0 Parent will be administered to parents at post-intervention and follow-up to assess changes in those areas endorsed at pre-intervention.


Other Outcome Measures:
  1. Treatment Acceptability Questionnaire [ Time Frame: 5-7 weeks ]
    Questionnaire about study acceptability will be administered at post test after the 5-7 week training.

  2. Treatment Evaluation Inventory [ Time Frame: 5-7 weeks ]
    Questionnaire evaluating treatment will be administered at post test after the 5-7 week training.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   10 Years to 17 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Williams syndrome (diagnosed with genetic testing)
  • Ages 10-17
  • First language and main language spoken in the home is English
  • Possess computer in the home that has internet access, and a second electronic device with access to Skype (e.g., smartphone, ipad, additional computer, ipod touch)

Exclusion Criteria:

  • First language and main language spoken in the home is NOT English (because study measures and instructions are all in English)
  • No computer in the home with internet access (because the study is being conducted via the internet)
  • Comorbid severe illnesses or major surgery within the past 6 months
  • Four or more previous sessions of inhibition training

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02212314


Locations
Layout table for location information
United States, Wisconsin
University of Wisconsin-Milwaukee Child Neurodevelopment Research Lab
Milwaukee, Wisconsin, United States, 53211
Sponsors and Collaborators
University of Wisconsin, Milwaukee
Investigators
Layout table for investigator information
Principal Investigator: Bonita P Klein-Tasman, Ph.D. University of Wisconsin, Milwaukee

Layout table for additonal information
Responsible Party: Bonita P Klein-Tasman, Professor, University of Wisconsin, Milwaukee
ClinicalTrials.gov Identifier: NCT02212314    
Other Study ID Numbers: 14.351
First Posted: August 8, 2014    Key Record Dates
Last Update Posted: May 31, 2017
Last Verified: May 2017
Keywords provided by Bonita P Klein-Tasman, University of Wisconsin, Milwaukee:
Response Inhibition, Williams Syndrome
Additional relevant MeSH terms:
Layout table for MeSH terms
Williams Syndrome
Syndrome
Disease
Pathologic Processes
Intellectual Disability
Neurobehavioral Manifestations
Neurologic Manifestations
Nervous System Diseases
Aortic Stenosis, Supravalvular
Aortic Valve Stenosis
Heart Valve Diseases
Heart Diseases
Cardiovascular Diseases
Chromosome Disorders
Congenital Abnormalities
Genetic Diseases, Inborn